Fund Overview of DSP Healthcare Fund Direct-idcw
-
₹3,190.1 CrAUM
-
₹27.52NAV
-
0.59%Expense Ratio
-
EquityFund Category
Returns of DSP Healthcare Fund Direct-idcw
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | -0.27% | NA | 6.12% |
| 6 Months | 11.22% | NA | 12.92% |
| 1 Year | -2.54% | -2.54% | 6.04% |
| 2 Years | 53.63% | 23.95% | 24.93% |
| 3 Years | 93.72% | 24.66% | 25.71% |
| 5 Years | 134.50% | 18.59% | 19.91% |
Dividends are declared by the fund house based on the income generated from the underlying assets. While many mutual funds distribute dividends annually, the payout frequency ultimately depends on the fund house’s decision
Asset Allocation
equities
98.70%other assets or cash equivalents
1.30%DSP Healthcare Fund Direct-idcw is one Equity mutual fund offered by DSP Mutual Fund. Launched on 30 Nov 2018, the fund aims Long term capital growth. Investment in equity and equity related Securities of healthcare and pharmaceutical companies. It manages assets worth ₹3,190.1 crore as on Thu Jul 31, 2025. The expense ratio stands at 0.59%. Fund Manager Manager EducationAbout DSP Healthcare Fund Direct-idcw
The portfolio allocation consists of 98.70% in equities, 1.30% in other assets or cash equivalents. Managed by Chirag Dagli, it has delivered a return of -2.54% in the last year, a total return since inception of 23.83%.
Key Metrics of DSP Healthcare Fund Direct-idcw
-
Standard Deviation14.59%
-
Sharpe Ratio1.23%
-
Alpha3.67%
-
Beta0.84%
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | 0.21% | 0.48% | 9.03% | 28.99% | 21.62% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | 0.12% | 0.25% | 8.10% | 27.87% | 20.55% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | -0.03% | -1.35% | 5.10% | 23.18% | 17.50% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | -0.13% | -1.67% | 3.76% | 21.53% | 15.83% |
More funds from DSP Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
DSP Healthcare Fund Regular - Growth
|
₹3,190 | 0.70% | -1.06% | 6.82% | -1.33% | 21.49% |
|
DSP Healthcare Fund Direct - Growth
|
₹3,190 | 0.82% | -0.73% | 7.55% | -0.01% | 23.13% |
|
DSP Healthcare Fund Regular-idcw
|
₹3,190 | 0.70% | -1.06% | 6.82% | -1.33% | 21.49% |
|
DSP Nifty Healthcare Index Fund Direct-growth
|
₹12 | 0.18% | 1.76% | - | - | - |
|
DSP Nifty Healthcare Index Fund Regular-growth
|
₹12 | 0.12% | 1.57% | - | - | - |
|
DSP Nifty Healthcare Index Fund Direct-idcw
|
₹12 | 0.18% | 1.76% | - | - | - |
|
DSP Nifty Healthcare Index Fund Regular-idcw
|
₹12 | 0.12% | 1.57% | - | - | - |
|
DSP Nifty Healthcare Etf - Growth
|
₹11 | 0.18% | 1.81% | 5.75% | 8.05% | - |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹40.45 | 27.87% | 20.55% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹43.71 | 28.99% | 21.62% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹34.41 | 23.18% | 17.50% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹31.21 | 21.53% | 15.83% | - |
| ICICI Prudential Nifty Healthcare Etf - Growth |
₹146 | ₹152.37 | 22.80% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.28 | 22.97% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Cipla Ltd | Healthcare | 8.73% | ₹278.35 Cr |
| Cipla Ltd | Healthcare | 8.76% | ₹269.16 Cr |
| Cipla Ltd | Healthcare | 8.76% | ₹269.16 Cr |
| Cipla Ltd | Healthcare | 8.55% | ₹268.80 Cr |
| Cipla Ltd | Healthcare | 8.55% | ₹268.80 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.22% | ₹262.08 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.26% | ₹259.62 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.26% | ₹259.62 Cr |
| Ipca Laboratories Ltd | Healthcare | 7.84% | ₹250.03 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 7.79% | ₹248.57 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 7.96% | ₹244.82 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 7.96% | ₹244.82 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 7.90% | ₹242.99 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 7.90% | ₹242.99 Cr |
| Ipca Laboratories Ltd | Healthcare | 7.39% | ₹227.15 Cr |
| Ipca Laboratories Ltd | Healthcare | 7.39% | ₹227.15 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 7.11% | ₹223.58 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 7.11% | ₹223.58 Cr |
| Ipca Laboratories Ltd | Healthcare | 6.86% | ₹215.64 Cr |
| Ipca Laboratories Ltd | Healthcare | 6.86% | ₹215.64 Cr |
| Laurus Labs Ltd | Healthcare | 6.73% | ₹211.51 Cr |
| Laurus Labs Ltd | Healthcare | 6.73% | ₹211.51 Cr |
| Laurus Labs Ltd | Healthcare | 6.08% | ₹193.92 Cr |
| Gland Pharma Ltd | Healthcare | 5.96% | ₹190.10 Cr |
| Laurus Labs Ltd | Healthcare | 6.07% | ₹186.70 Cr |
| Laurus Labs Ltd | Healthcare | 6.07% | ₹186.70 Cr |
| Gland Pharma Ltd | Healthcare | 5.96% | ₹183.36 Cr |
| Gland Pharma Ltd | Healthcare | 5.96% | ₹183.36 Cr |
| Gland Pharma Ltd | Healthcare | 5.65% | ₹177.59 Cr |
| Gland Pharma Ltd | Healthcare | 5.65% | ₹177.59 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 5.59% | ₹175.81 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 5.59% | ₹175.81 Cr |
| Sai Life Sciences Ltd. | Healthcare | 5.23% | ₹164.56 Cr |
| Sai Life Sciences Ltd. | Healthcare | 5.23% | ₹164.56 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.76% | ₹149.60 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.76% | ₹149.60 Cr |
| Sai Life Sciences Ltd. | Healthcare | 4.77% | ₹146.58 Cr |
| Sai Life Sciences Ltd. | Healthcare | 4.77% | ₹146.58 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.58% | ₹146.04 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.69% | ₹144.30 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.69% | ₹144.30 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 4.52% | ₹144.25 Cr |
| Globus Medical Inc Forgn. Eq (gmed) | Healthcare | 4.58% | ₹144.02 Cr |
| Globus Medical Inc Forgn. Eq (gmed) | Healthcare | 4.58% | ₹144.02 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 4.38% | ₹139.66 Cr |
| Sai Life Sciences Ltd. | Healthcare | 4.32% | ₹137.68 Cr |
| Globus Medical Inc Forgn. Eq (gmed) | Healthcare | 4.45% | ₹136.69 Cr |
| Globus Medical Inc Forgn. Eq (gmed) | Healthcare | 4.45% | ₹136.69 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 4.40% | ₹135.26 Cr |
| Illumina Inc. (usa) Forgn. Eq (ilmn) | Healthcare | 4.40% | ₹135.26 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 4.19% | ₹128.73 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 4.19% | ₹128.73 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 4.08% | ₹128.16 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 4.08% | ₹128.16 Cr |
| Globus Medical Inc Forgn. Eq (gmed) | Healthcare | 3.88% | ₹123.87 Cr |
| Kovai Medical Center & Hospital Ltd | Healthcare | 3.36% | ₹105.69 Cr |
| Kovai Medical Center & Hospital Ltd | Healthcare | 3.36% | ₹105.69 Cr |
| Pfizer Ltd | Healthcare | 3.32% | ₹104.52 Cr |
| Pfizer Ltd | Healthcare | 3.32% | ₹104.52 Cr |
| Pfizer Ltd | Healthcare | 3.27% | ₹104.22 Cr |
| Kovai Medical Center & Hospital Ltd | Healthcare | 3.23% | ₹103.18 Cr |
| Indoco Remedies Ltd | Healthcare | 3.22% | ₹102.78 Cr |
| Kovai Medical Center & Hospital Ltd | Healthcare | 3.29% | ₹101.29 Cr |
| Kovai Medical Center & Hospital Ltd | Healthcare | 3.29% | ₹101.29 Cr |
| Pfizer Ltd | Healthcare | 3.29% | ₹101.04 Cr |
| Pfizer Ltd | Healthcare | 3.29% | ₹101.04 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 3.15% | ₹100.57 Cr |
| Procter & Gamble Health Ltd | Healthcare | 3.27% | ₹100.47 Cr |
| Procter & Gamble Health Ltd | Healthcare | 3.27% | ₹100.47 Cr |
| Procter & Gamble Health Ltd | Healthcare | 3.12% | ₹98.22 Cr |
| Procter & Gamble Health Ltd | Healthcare | 3.12% | ₹98.22 Cr |
| Indoco Remedies Ltd | Healthcare | 3.07% | ₹94.40 Cr |
| Indoco Remedies Ltd | Healthcare | 3.07% | ₹94.40 Cr |
| Procter & Gamble Health Ltd | Healthcare | 2.94% | ₹93.91 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 3.04% | ₹93.55 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 3.04% | ₹93.55 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 2.94% | ₹92.49 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 2.94% | ₹92.49 Cr |
| Indoco Remedies Ltd | Healthcare | 2.87% | ₹90.26 Cr |
| Indoco Remedies Ltd | Healthcare | 2.87% | ₹90.26 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 2.83% | ₹88.97 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 2.83% | ₹88.97 Cr |
| Concord Biotech Ltd. | Healthcare | 2.71% | ₹86.56 Cr |
| Concord Biotech Ltd. | Healthcare | 2.63% | ₹80.70 Cr |
| Concord Biotech Ltd. | Healthcare | 2.63% | ₹80.70 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 2.48% | ₹79.06 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 2.42% | ₹74.53 Cr |
| Intuitive Surgical Inc. (usa) Forgn. Eq (isrg) | Healthcare | 2.42% | ₹74.53 Cr |
| Reverse Repo | Unspecified | 2.34% | ₹71.98 Cr |
| Reverse Repo | Unspecified | 2.34% | ₹71.98 Cr |
| Concord Biotech Ltd. | Healthcare | 2.25% | ₹70.71 Cr |
| Concord Biotech Ltd. | Healthcare | 2.25% | ₹70.71 Cr |
| Reverse Repo | Unspecified | 1.90% | ₹60.53 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.74% | ₹55.44 Cr |
| Unichem Laboratories Ltd | Healthcare | 1.67% | ₹53.12 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.65% | ₹51.87 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.65% | ₹51.87 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.64% | ₹50.34 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.64% | ₹50.34 Cr |
| Icici Lombard General Insurance Company Ltd | Financial | 1.53% | ₹48.13 Cr |
| Icici Lombard General Insurance Company Ltd | Financial | 1.53% | ₹48.13 Cr |
| Reverse Repo | Unspecified | 1.51% | ₹47.42 Cr |
| Reverse Repo | Unspecified | 1.51% | ₹47.42 Cr |
| Icici Lombard General Insurance Company Ltd | Financial | 1.46% | ₹46.52 Cr |
| Icici Lombard General Insurance Company Ltd | Financial | 1.48% | ₹45.62 Cr |
| Icici Lombard General Insurance Company Ltd | Financial | 1.48% | ₹45.62 Cr |
| Aarti Drugs Ltd | Healthcare | 1.35% | ₹43.18 Cr |
| Aarti Drugs Ltd | Healthcare | 1.33% | ₹41.85 Cr |
| Aarti Drugs Ltd | Healthcare | 1.33% | ₹41.85 Cr |
| Aarti Drugs Ltd | Healthcare | 1.35% | ₹41.46 Cr |
| Aarti Drugs Ltd | Healthcare | 1.35% | ₹41.46 Cr |
| Unichem Laboratories Ltd | Healthcare | 1.28% | ₹40.13 Cr |
| Unichem Laboratories Ltd | Healthcare | 1.28% | ₹40.13 Cr |
| Unichem Laboratories Ltd | Healthcare | 1.28% | ₹39.31 Cr |
| Unichem Laboratories Ltd | Healthcare | 1.28% | ₹39.31 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.22% | ₹37.58 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.22% | ₹37.58 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.09% | ₹34.91 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.10% | ₹34.66 Cr |
| Abbott Laboratories Forgn. Eq (abt) | Healthcare | 1.10% | ₹34.66 Cr |
| Thyrocare Technologies Ltd | Healthcare | 0.95% | ₹30.37 Cr |
| Thyrocare Technologies Ltd | Healthcare | 0.82% | ₹25.66 Cr |
| Thyrocare Technologies Ltd | Healthcare | 0.82% | ₹25.66 Cr |
| Global X Genomics & Biotechnology Etf | Unspecified | 0.79% | ₹24.69 Cr |
| Global X Genomics & Biotechnology Etf | Unspecified | 0.79% | ₹24.69 Cr |
| Thyrocare Technologies Ltd | Healthcare | 0.69% | ₹21.32 Cr |
| Thyrocare Technologies Ltd | Healthcare | 0.69% | ₹21.32 Cr |
| Global X Genomics & Biotechnology Etf | Unspecified | 0.69% | ₹21.12 Cr |
| Global X Genomics & Biotechnology Etf | Unspecified | 0.69% | ₹21.12 Cr |
| Alkem Laboratories Ltd | Healthcare | 0.65% | ₹20.56 Cr |
| Alkem Laboratories Ltd | Healthcare | 0.65% | ₹20.56 Cr |
| Alkem Laboratories Ltd | Healthcare | 0.66% | ₹20.25 Cr |
| Alkem Laboratories Ltd | Healthcare | 0.66% | ₹20.25 Cr |
| Alkem Laboratories Ltd | Healthcare | 0.59% | ₹18.78 Cr |
| Global X Genomics & Biotechnology Etf | Unspecified | 0.58% | ₹18.60 Cr |
| Medplus Health Services Ltd | Healthcare | 0.56% | ₹17.87 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 0.48% | ₹14.95 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 0.48% | ₹14.95 Cr |
| Medplus Health Services Ltd | Healthcare | 0.47% | ₹14.65 Cr |
| Medplus Health Services Ltd | Healthcare | 0.47% | ₹14.65 Cr |
| Medplus Health Services Ltd | Healthcare | 0.47% | ₹14.55 Cr |
| Medplus Health Services Ltd | Healthcare | 0.47% | ₹14.55 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 0.47% | ₹14.31 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 0.47% | ₹14.31 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 0.42% | ₹13.46 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.37% | ₹11.83 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.30% | ₹9.12 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.30% | ₹9.12 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.28% | ₹8.81 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.28% | ₹8.81 Cr |
| Grail Inc | Healthcare | 0.23% | ₹7.12 Cr |
| Grail Inc | Healthcare | 0.23% | ₹7.12 Cr |
| Grail Inc | Healthcare | 0.15% | ₹4.59 Cr |
| Grail Inc | Healthcare | 0.15% | ₹4.59 Cr |
| Grail Inc | Healthcare | 0.08% | ₹2.62 Cr |
| Net Payables | Unspecified | -0.06% | ₹-1.92 Cr |
| Net Payables | Unspecified | -0.21% | ₹-6.38 Cr |
| Net Payables | Unspecified | -0.21% | ₹-6.38 Cr |
| Net Payables | Unspecified | -0.29% | ₹-9.09 Cr |
| Net Payables | Unspecified | -0.29% | ₹-9.09 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹43.71 | 28.99% | 21.62% | 44.69 |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹40.45 | 27.87% | 20.55% | 41.47 |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹34.41 | 23.18% | 17.50% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹31.21 | 21.53% | 15.83% | - |
DSP Healthcare Fund Direct-idcw
What is the current AUM of DSP Healthcare Fund Direct-idcw?
As of Thu Jul 31, 2025, DSP Healthcare Fund Direct-idcw manages assets worth ₹3,190.1 crore
How has DSP Healthcare Fund Direct-idcw performed recently?
- 3 Months: -0.27%
- 6 Months: 11.22%
What is the long-term performance of DSP Healthcare Fund Direct-idcw?
- 3 Years CAGR: 24.66%
- 5 Years CAGR: 18.59%
- Since Inception: 23.83%
What is the portfolio composition of DSP Healthcare Fund Direct-idcw?
Equity: 98.70%, Others: 1.30%.
Who manages DSP Healthcare Fund Direct-idcw?
DSP Healthcare Fund Direct-idcw is managed by Chirag Dagli from DSP Mutual Fund.
When was the last dividend declared by DSP Healthcare Fund Direct-idcw?
Latest dividend was declared on 28 Feb 2025 at 23.00% of face value.
What is the market-cap allocation of DSP Healthcare Fund Direct-idcw?
Large Cap: 31.83%, Mid Cap: 20.83%, Small Cap: 47.34%.
Which are the top companies DSP Healthcare Fund Direct-idcw has invested in?
- Cipla Ltd – 8.73% of the fund's portfolio
- Cipla Ltd – 8.76% of the fund's portfolio
- Cipla Ltd – 8.76% of the fund's portfolio
- Cipla Ltd – 8.55% of the fund's portfolio
- Cipla Ltd – 8.55% of the fund's portfolio
Which are the major sectors DSP Healthcare Fund Direct-idcw focuses on?
- Healthcare – 480.44% of the fund's portfolio
- Unspecified – 12.08% of the fund's portfolio
- Financial – 7.48% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.


